ACRS Financial Statements

Balance sheet, income statement, cash flow, and dividends for Aclaris Therapeutics Inc (ACRS).


$177.15M Market Cap.

As of 02/28/2025 5:00 PM ET (MRY) • Disclaimer

ACRS Market Cap. (MRY)


ACRS Shares Outstanding (MRY)


ACRS Assets (MRY)


Total Assets

$220.33M

Total Liabilities

$64.77M

Total Investments

$179.33M

ACRS Income (MRY)


Revenue

$18.72M

Net Income

-$132.06M

Operating Expense

$142.69M

ACRS Cash Flow (MRY)


CF Operations

-$20.07M

CF Investing

-$69.77M

CF Financing

$74.54M

ACRS Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

ACRS Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$220,327,000 (11.61%)

$197,405,000 (-22.46%)

$254,596,000 (1.35%)

$251,211,000 (254.90%)

Assets Current

$125,951,000 (-2.25%)

$128,856,000 (-44.35%)

$231,550,000 (12.93%)

$205,032,000 (256.62%)

Assets Non-Current

$94,376,000 (37.68%)

$68,549,000 (197.44%)

$23,046,000 (-50.09%)

$46,179,000 (247.45%)

Goodwill & Intangible Assets

$0 (0%)

$269,000 (-96.14%)

$6,973,000 (-1.06%)

$7,048,000 (-1.05%)

Shareholders Equity

$155,554,000 (-1.03%)

$157,179,000 (-20.46%)

$197,621,000 (0.14%)

$197,341,000 (424.15%)

Property Plant & Equipment Net

$1,008,000 (-37.78%)

$1,620,000 (47.41%)

$1,099,000 (-17.68%)

$1,335,000 (-19.29%)

Cash & Equivalents

$24,570,000 (-38.39%)

$39,878,000 (-11.92%)

$45,277,000 (65.55%)

$27,349,000 (23.96%)

Accumulated Other Comprehensive Income

$97,000 (191.51%)

-$106,000 (88.18%)

-$897,000 (-300.45%)

-$224,000 (-138.30%)

Deferred Revenue

$23,928,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$179,326,000 (26.29%)

$141,999,000 (-23.05%)

$184,536,000 (-6.94%)

$198,307,000 (518.40%)

Investments Current

$89,024,000 (12.36%)

$79,228,000 (-54.02%)

$172,294,000 (5.02%)

$164,065,000 (411.62%)

Investments Non-Current

$90,302,000 (43.86%)

$62,771,000 (412.75%)

$12,242,000 (-64.25%)

$34,242,000 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$318,000 (6.71%)

$298,000 (-38.43%)

$484,000 (-22.31%)

$623,000 (-19.30%)

Trade & Non-Trade Payables

$4,690,000 (-47.17%)

$8,878,000 (-14.23%)

$10,351,000 (3.67%)

$9,985,000 (90.05%)

Accumulated Retained Earnings (Deficit)

-$902,861,000 (-17.13%)

-$770,796,000 (-12.97%)

-$682,315,000 (-14.60%)

-$595,407,000 (-18.01%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$367,000 (0.00%)

$367,000 (0.00%)

Total Debt

$0 (0%)

$426,000 (-37.72%)

$684,000 (-1.30%)

$693,000 (-93.84%)

Debt Current

$0 (0%)

$426,000 (-37.72%)

$684,000 (-1.30%)

$693,000 (14.93%)

Debt Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Liabilities

$64,773,000 (61.02%)

$40,226,000 (-29.40%)

$56,975,000 (5.76%)

$53,870,000 (62.58%)

Liabilities Current

$31,596,000 (2.08%)

$30,952,000 (41.09%)

$21,938,000 (-4.33%)

$22,931,000 (54.17%)

Liabilities Non-Current

$33,177,000 (257.74%)

$9,274,000 (-73.53%)

$35,037,000 (13.25%)

$30,939,000 (69.44%)

ACRS Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$18,720,000 (-40.09%)

$31,249,000 (5.03%)

$29,752,000 (340.05%)

$6,761,000 (4.30%)

Cost of Revenue

$15,458,000 (-14.51%)

$18,081,000 (51.18%)

$11,960,000 (153.77%)

$4,713,000 (-8.18%)

Selling General & Administrative Expense

$22,203,000 (-31.50%)

$32,412,000 (28.96%)

$25,133,000 (6.41%)

$23,619,000 (15.05%)

Research & Development Expense

$33,586,000 (-65.86%)

$98,384,000 (26.44%)

$77,813,000 (77.60%)

$43,813,000 (49.34%)

Operating Expenses

$142,694,000 (3.83%)

$137,425,000 (33.49%)

$102,946,000 (52.67%)

$67,432,000 (35.22%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

-$367,000 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$132,065,000 (-49.26%)

-$88,481,000 (-1.81%)

-$86,908,000 (4.35%)

-$90,865,000 (-78.11%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$132,065,000 (-49.26%)

-$88,481,000 (-1.81%)

-$86,908,000 (4.35%)

-$90,865,000 (-78.11%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$132,065,000 (-49.26%)

-$88,481,000 (-1.81%)

-$86,908,000 (4.35%)

-$90,865,000 (-78.11%)

Weighted Average Shares

$77,296,665 (10.73%)

$69,808,855 (7.05%)

$65,213,944 (14.95%)

$56,730,583 (33.36%)

Weighted Average Shares Diluted

$77,296,665 (10.73%)

$69,808,855 (7.05%)

$65,213,944 (14.95%)

$56,730,583 (33.36%)

Earning Before Interest & Taxes (EBIT)

-$132,065,000 (-48.64%)

-$88,848,000 (-2.23%)

-$86,908,000 (4.35%)

-$90,865,000 (-77.48%)

Gross Profit

$3,262,000 (-75.23%)

$13,168,000 (-25.99%)

$17,792,000 (768.75%)

$2,048,000 (51.82%)

Operating Income

-$139,432,000 (-12.21%)

-$124,257,000 (-45.92%)

-$85,154,000 (-30.24%)

-$65,384,000 (-34.76%)

ACRS Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$69,769,000 (-250.95%)

$46,220,000 (266.01%)

$12,628,000 (107.53%)

-$167,632,000 (-2724.58%)

Net Cash Flow from Financing

$74,536,000 (179.10%)

$26,706,000 (-63.35%)

$72,867,000 (-67.62%)

$225,052,000 (1124.97%)

Net Cash Flow from Operations

-$20,075,000 (74.37%)

-$78,325,000 (-15.92%)

-$67,567,000 (-29.60%)

-$52,134,000 (-34.95%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$15,308,000 (-183.53%)

-$5,399,000 (-130.11%)

$17,928,000 (239.16%)

$5,286,000 (138.10%)

Net Cash Flow - Business Acquisitions and Disposals

-$35,810,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$33,838,000 (-171.19%)

$47,529,000 (259.17%)

$13,233,000 (107.91%)

-$167,324,000 (-2546.26%)

Capital Expenditure

-$121,000 (90.76%)

-$1,309,000 (-116.36%)

-$605,000 (-96.43%)

-$308,000 (32.01%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

-$11,483,000 (-206.56%)

Issuance (Purchase) of Equity Shares

$74,945,000 (179.56%)

$26,808,000 (-63.23%)

$72,901,000 (-69.58%)

$239,659,000 (2969.80%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$10,856,000 (-47.15%)

$20,542,000 (36.59%)

$15,039,000 (6.96%)

$14,060,000 (25.46%)

Depreciation Amortization & Accretion

$807,000 (-6.49%)

$863,000 (8.28%)

$797,000 (-13.65%)

$923,000 (-30.29%)

ACRS Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

17.40% (-58.67%)

42.10% (-29.60%)

59.80% (97.36%)

30.30% (45.67%)

Profit Margin

-705.50% (-149.21%)

-283.10% (3.08%)

-292.10% (78.27%)

-1344.00% (-70.78%)

EBITDA Margin

-701.20% (-149.01%)

-281.60% (2.70%)

-289.40% (78.25%)

-1330.30% (-72.90%)

Return on Average Equity (ROAE)

-94.10% (-78.22%)

-52.80% (-26.62%)

-41.70% (12.76%)

-47.80% (56.43%)

Return on Average Assets (ROAA)

-71.60% (-78.11%)

-40.20% (-18.58%)

-33.90% (10.08%)

-37.70% (40.06%)

Return on Sales (ROS)

-705.50% (-148.15%)

-284.30% (2.67%)

-292.10% (78.27%)

-1344.00% (-70.17%)

Return on Invested Capital (ROIC)

-101.40% (-73.33%)

-58.50% (-20.37%)

-48.60% (11.80%)

-55.10% (62.16%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-1.45 (-75.33%)

-0.83 (93.02%)

-11.84 (-30.30%)

-9.09 (-68.55%)

Price to Sales Ratio (P/S)

10.24 (336.49%)

2.35 (-93.20%)

34.52 (-71.70%)

122 (187.33%)

Price to Book Ratio (P/B)

1.14 (140.80%)

0.47 (-91.10%)

5.32 (17.82%)

4.51 (-38.84%)

Debt to Equity Ratio (D/E)

0.42 (62.50%)

0.26 (-11.11%)

0.29 (5.49%)

0.27 (-68.98%)

Earnings Per Share (EPS)

-1.71 (-34.65%)

-1.27 (4.51%)

-1.33 (16.88%)

-1.6 (-33.33%)

Sales Per Share (SPS)

0.24 (-45.98%)

0.45 (-1.75%)

0.46 (283.19%)

0.12 (-21.71%)

Free Cash Flow Per Share (FCFPS)

-0.26 (77.13%)

-1.14 (-9.19%)

-1.04 (-13.10%)

-0.92 (-0.54%)

Book Value Per Share (BVPS)

2.01 (-10.66%)

2.25 (-25.68%)

3.03 (-12.91%)

3.48 (293.11%)

Tangible Assets Book Value Per Share (TABVPS)

2.85 (0.92%)

2.82 (-25.63%)

3.8 (-11.78%)

4.3 (187.51%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (0%)

0 (0%)

-11 (-22.22%)

-9 (-80.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.99 (-143.70%)

-0.41 (96.48%)

-11.49 (-23.43%)

-9.31 (-76.21%)

Asset Turnover

0.1 (-28.87%)

0.14 (22.41%)

0.12 (314.29%)

0.03 (-65.00%)

Current Ratio

3.99 (-4.25%)

4.16 (-60.56%)

10.55 (18.05%)

8.94 (131.33%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$20,196,000 (74.64%)

-$79,634,000 (-16.81%)

-$68,172,000 (-30.00%)

-$52,442,000 (-34.17%)

Enterprise Value (EV)

$129,497,736 (263.27%)

$35,648,004 (-96.40%)

$989,373,258 (18.16%)

$837,312,422 (217.77%)

Earnings Before Tax (EBT)

-$132,065,000 (-48.64%)

-$88,848,000 (-2.23%)

-$86,908,000 (4.35%)

-$90,865,000 (-77.48%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$131,258,000 (-49.18%)

-$87,985,000 (-2.18%)

-$86,111,000 (4.26%)

-$89,942,000 (-80.34%)

Invested Capital

$164,161,000 (29.53%)

$126,732,000 (-30.02%)

$181,092,000 (-6.93%)

$194,576,000 (412.31%)

Working Capital

$94,355,000 (-3.62%)

$97,904,000 (-53.29%)

$209,612,000 (15.11%)

$182,101,000 (327.28%)

Tangible Asset Value

$220,327,000 (11.76%)

$197,136,000 (-20.39%)

$247,623,000 (1.42%)

$244,163,000 (283.54%)

Market Capitalization

$177,148,736 (138.17%)

$74,378,004 (-92.92%)

$1,050,260,258 (17.97%)

$890,245,422 (220.59%)

Average Equity

$140,385,250 (-16.20%)

$167,518,000 (-19.60%)

$208,352,500 (9.65%)

$190,007,750 (308.73%)

Average Assets

$184,464,250 (-16.26%)

$220,278,250 (-14.18%)

$256,682,750 (6.49%)

$241,037,500 (197.12%)

Invested Capital Average

$130,196,750 (-14.30%)

$151,921,500 (-15.06%)

$178,856,500 (8.39%)

$165,011,250 (369.17%)

Shares

71,430,942 (0.84%)

70,836,194 (6.23%)

66,683,191 (8.91%)

61,227,333 (42.66%)